Lavera launches U.S. test program
This article was originally published in The Rose Sheet
Executive Summary
German naturals firm Lavera will launch its products in six Harmon stores in New Jersey and two Bed Bath & Beyond stores in New York beginning in the spring under a deal announced Jan. 7. Harmon, a key health and beauty retailer in the Atlantic Northeast region, is a subsidiary of housewares store Bed Bath & Beyond. "Harmon is a very progressive company. It has built its success and reputation on providing the best, price-competitive choices for its customers, and we believe that inclusion of our organic and natural skin-care products will be particularly well appreciated by their customers," says Ulrike Jacob-Dewor, CEO of Lavera North America. Lavera holds 27% market share in general health and beauty products in Europe. Its offerings currently are sold in the U.S. and Canada in Whole Foods, Wegmans, Rexall and Pharma Plus doors, as well as independent natural products stores...
You may also be interested in...
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.